Form 6-K China Nepstar Chain Drug For: Aug 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
China Nepstar Chain Drugstore (NPD) Reports Q2 Loss of RMB0.16/Share
August 28, 2014 6:24 AM EDTChina Nepstar Chain Drugstore (NYSE: NPD) reported Q2 EPS of (RMB0.16), versus (RMB0.04) reported last year. Revenue for the quarter came in at RMB686.6 million, versus RMB538.8 million reported last year.
For earnings history and earnings-related data on China Nepstar Chain Drugstore (NPD) click here.
... More